Report error Found 15 Enz. Inhib. hit(s) with all data for entry = 11955
TargetSolute carrier family 22 member 12(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 54.5nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 80.4nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 585nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
3D Structure (crystal)TargetSolute carrier family 22 member 12(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.09E+3nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.16E+3nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.18E+3nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 2.79E+3nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 3.15E+3nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 3.42E+3nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 6(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 6.51E+3nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 6(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.27E+4nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 11(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 2.74E+4nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 8(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 4.04E+4nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 11(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 8.38E+4nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 8(Human)
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:Experimental results: The compounds had no obvious inhibitory effect on the drug transporter OAT3, and when the compounds were used clinically in com...More data for this Ligand-Target Pair
